Home Beauty Health Big pharma can only see the benefit of R&D for wealthy markets - There is too little incentive for pharmaceutical companies to work on treatments for diseases of low-income countries

on May 05, 2019
Big pharma can only see the benefit of R&D for wealthy markets - There is too little incentive for pharmaceutical companies to work on treatments for diseases of low-income countries submitted by /u/mvea
[link] [comments]


from Health http://bit.ly/2DP7lwZ
,
Share To:

Unknown

View Profile

Post A Comment:

0 comments so far,add yours

Subscribe to: Post Comments (Atom)